Condition: Locally Advanced Pancreatic Adenocarcinoma · Sponsor: EXACT Therapeutics AS
The purpose of the study is to assess the efficacy and safety of Acoustic Cluster Therapy (ACT) when given in addition to chemotherapy for treatment of Locally Advanced Pancreatic Cancer.
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| HonorHealth Research Institute | Scottsdale, Arizona, United States | Recruiting |
| Stanford Cancer Center Palo Alto | Stanford, California, United States | Recruiting |
| Beth Israel Deaconess Medical Center - Division of Hematology/Oncology | Boston, Massachusetts, United States | Recruiting |
| Henry Ford Centre | Detroit, Michigan, United States | Recruiting |
| Sidney Kimmel Cancer Center, Thomas Jefferson University Hospital | Philadelphia, Pennsylvania, United States | Recruiting |
| Allegheny General Hospital | Pittsburgh, Pennsylvania, United States | Recruiting |
| Brown University Cancer Institute | Providence, Rhode Island, United States | Recruiting |
| CAMBRIDGE CANCER TRIALS CENTRE-Addenbrooke's Hospital | Cambridge, Cambridge, United Kingdom | Recruiting |
| Gary Weston Centre- Imperial College Healthcare- Du Cane Road | Hammersmith, London, United Kingdom | Recruiting |
| The Royal Marsden- Downs Road | Sutton, Surrey, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06850623